Euro-Med Laboratories Phil., Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021
August 12, 2021 at 12:44 am EDT
Share
Euro-Med Laboratories Phil., Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was PHP 860.517 million compared to PHP 764.091 million a year ago. Net income was PHP 22.378 million compared to PHP 16.290 million a year ago. Basic earnings per share from continuing operations was PHP 0.01. For the half year, sales was PHP 1,654.991 million compared to PHP 1,949.955 million a year ago. Net income was PHP 52.308 million compared to PHP 62.665 million a year ago. Basic earnings per share from continuing operations was PHP 0.01 compared to PHP 0.02 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
